Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesAlcohol and Risk of Breast Cancer by Histologic Type and Hormone Receptor Status in Postmenopausal Women
American Journal of Epidemiology, 06/19/09
Lew JQ et al. - Moderate consumption of alcohol was associated with breast cancer, specifically hormone receptor-positive tumors.
Related Articles
Alcohol control policies and alcohol consumption by youth: a multi-national study
Addiction, 10/19/09
Relevance Score: 94%
Teenage drinking, alcohol availability and pricing: a cross-sectional study of risk and protective factors for alcohol-related harms in school children
BMC Public Health, 10/12/09
Relevance Score: 93%
The Long Arm of Expectancies: Adolescent Alcohol Expectancies Predict Adult Alcohol Use
Alcohol and Alcoholism, 10/12/09
Relevance Score: 93%
Changes in per capita alcohol sales during the partial privatization of British Columbias retail alcohol monopoly 20032008: a multi-level local area analysis
Addiction, 10/19/09
Relevance Score: 91%
Increased Acid Sphingomyelinase Activity in Peripheral Blood Cells of Acutely Intoxicated Patients With Alcohol Dependence
Alcoholism, 10/29/09
Relevance Score: 90%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer
Breast Cancer Research and Treatment, 12/02/09
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer
Breast Cancer Research and Treatment, 12/02/09
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
Breast Cancer Research and Treatment, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor